Genetic testing for Lynch Syndrome prevents cancers being missed
Genetic testing for Lynch Syndrome must increase to prevents cancers being missed
Related Articles
Revisit Every OncLive On Air Episode From December 2024
In case you missed any, read a recap of the episodes of OncLive On Air that aired in December 2024.
Genetic counseling comes to CH Hospital – The Chestnut Hill Local
Fox Chase Cancer Center has expanded its genetic counseling and high-risk breast cancer services to Temple Health – Chestnut Hill Hospital.
Blood Podcast | Blood | American Society of Hematology
Blood Podcast | Blood | American Society of Hematology Blood Podcast  The editors of Blood are pleased to introduce a podcast series, published weekly…
NCCN publishes patient resource on genetic testing to guide patient decisionmaking – The Cancer Letter
The National Comprehensive Cancer Network published its first patient resource aimed at informing people about the latest recommendations around hereditary and familial cancer risk. The…
Cedars-Sinai Cancer’s model of care ensured patient care amid wildfires – The Cancer Letter
Over the past five years, Cedars-Sinai Cancer has built an integrated, regional system designed to provide cancer care close to where patients live and work.…
Understanding Graft-VS-Host Disease (GVHD) Basics
Panelists discuss how graft-vs-host disease (GVHD) is a complex immune-mediated condition, highlighting the differences between acute and chronic GVHD, the associated risk factors, prognosis, and…
Metastatic Breast Cancer Support and Education | Dana-Farber Cancer Institute
One of the goals of the Ending Metastatic Breast Cancer for Everyone (EMBRACE) program at Dana-Farber Cancer Institute is to provide resources and information to…
ACS report: Cancer mortality continues to drop despite rising incidence in women – The Cancer Letter
Despite steady progress in reducing overall cancer mortality rates, cancer incidence in women is rising, according to the American Cancer Society’s “Cancer Statistics, 2025” report.…
FDA and OHRP draft guidance aims to improve ethics of tissue biopsies in clinical trials – The Cancer Letter
The U.S. Food and Drug Administration and the U.S. Department of Health and Human Services Office of Human Research Protections issued Draft Guidance on the…
Rathmell steps down at NCI as Trump team considers candidates to replace her Wafik El-Deiry, Harvey Risch have been interviewed – The Cancer Letter
W. Kimryn Rathmell has stepped down as NCI director, opting to hand her resignation to the Biden administration over facing the uncertainties that Trump and…